Seqirus, a global vaccine maker with a newly expanded manufacturing plant in Holly Springs, has signed a $30.1 million federal contract to produce a potential vaccine against avian flu.
Read More
Seqirus Holly Springs held a ribbon cutting Monday morning to celebrate its expansion and new recognition for pandemic vaccine production and distribution. Last week, the U.S. government declared Seqirus, one of the largest influenza vaccine manufacturers in the world, “pandemic ready” to produce and distribute 150 million doses of...
Read More
Seqirus, which is expanding its Holly Springs facility, extended a partnership with BARDA to provide vaccinations against influenza strains, now and in future.
Read More
Flu vaccine producer Seqirus will work with the U.S. government to develop two vaccine candidates to combat future pandemics. Here’s a detailed look at what’s happening.
Read More
Seqirus will develop two vaccines against the seasonal flu from its Holly Springs manufacturing facility, and has won a multi-year federal contract for $34.95 million to do so.
Read More
RESEARCH TRIANGLE PARK – Seqirus hopes to raise the bar on flu prevention with the accelerated development of its next-generation influenza vaccine technology, called self-amplifying messenger RNA – or sa-mRNA. The Summit, New Jersey-based company is one of the largest flu vaccine manufacturers in the world. It operates a massive...
Read More
With most of the world currently focused on the rapid spread of the Delta variant of COVID-19, we shouldn’t forget that flu season also is just around the corner.
Read More
Although most of us currently are consumed by the COVID-19 coronavirus, it’s also the season to be thinking about the flu. Seqirus isn’t and touts its vaccine data.
Read More
While the world’s leading infectious disease experts consider whether the coronavirus that originated in Wuhan, China, could become the next pandemic, a Holly Springs company is working on a vaccine to protect humans from another deadly virus.
Read More
